MICHELLE KUKIELSKI: Open Payments
NPI 1578053013 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,649 in 158 payments from 18 companies in 2025. Trend: 2023 $2,095 · 2024 $3,223 · 2025 $3,649
Food & beverage: $3,481Education: $168
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $760 |
| Janssen Biotech, Inc. | 15 | $501 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $437 |
| Ardelyx, Inc. | 14 | $378 |
| Phathom Pharmaceuticals, Inc. | 8 | $275 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $212 |
| Madrigal Pharmaceuticals | 8 | $197 |
| Aimmune Therapeutics, Inc. | 10 | $158 |
| QOL Medical, LLC | 8 | $153 |
| PFIZER INC. | 7 | $131 |
Products named: TREMFYA, IBSRELA, ENTYVIO, RINVOQ, SKYRIZI, VOQUEZNA, DUPIXENT, REZDIFFRA.
Industry payments across TX — which companies pay providers there.
